| Nucleoprotein | N; Nucleocapsid protein; NC; Protein N | Severe acute respiratory syndrome coronavirus 2 |
| Target of rapamycin complex 2 subunit MAPKAP1 | TORC2 subunit MAPKAP1; Mitogen-activated protein kinase 2-associated protein 1; Stress-activated map kinase-interacting protein 1; SAPK-interacting protein 1; mSIN1 | Homo sapiens (human) |
| 3-phosphoinositide-dependent protein kinase 1 | hPDK1; EC 2.7.11.1 | Homo sapiens (human) |
| Tyrosine-protein kinase Fyn | EC 2.7.10.2; Proto-oncogene Syn; Proto-oncogene c-Fyn; Src-like kinase; SLK; p59-Fyn | Homo sapiens (human) |
| Mitogen-activated protein kinase kinase kinase 8 | EC 2.7.11.25; Cancer Osaka thyroid oncogene; Proto-oncogene c-Cot; Serine/threonine-protein kinase cot; Tumor progression locus 2; TPL-2 | Homo sapiens (human) |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | PI3-kinase subunit alpha; PI3K-alpha; PI3Kalpha; PtdIns-3-kinase subunit alpha; EC 2.7.1.137; EC 2.7.1.153; Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha; PtdIns-3-kinase subunit p110-alpha; p110alpha; Phosphoinositide 3-k | Homo sapiens (human) |
| Serine/threonine-protein kinase PAK 1 | EC 2.7.11.1; Alpha-PAK; p21-activated kinase 1; PAK-1; p65-PAK | Homo sapiens (human) |
| T-cell-specific surface glycoprotein CD28 | TP44 | Homo sapiens (human) |
| Serine/threonine-protein kinase PAK 3 | EC 2.7.11.1; Beta-PAK; Oligophrenin-3; p21-activated kinase 3; PAK-3 | Homo sapiens (human) |
| Serine/threonine-protein kinase mTOR | EC 2.7.11.1; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Mammalian target of rapamycin; mTOR; Mechanistic target of rapamycin; Rapamycin and FKBP12 target 1; Rapamycin target protein 1 | Homo sapiens (human) |
| Cell division control protein 42 homolog | EC 3.6.5.2; G25K GTP-binding protein | Homo sapiens (human) |
| Mitogen-activated protein kinase kinase kinase 14 | EC 2.7.11.25; NF-kappa-beta-inducing kinase; HsNIK; Serine/threonine-protein kinase NIK | Homo sapiens (human) |
| Ras-related C3 botulinum toxin substrate 1 | EC 3.6.5.2; Cell migration-inducing gene 5 protein; Ras-like protein TC25; p21-Rac1 | Homo sapiens (human) |
| Serine/threonine-protein kinase PAK 2 | EC 2.7.11.1; Gamma-PAK; PAK65; S6/H4 kinase; p21-activated kinase 2; PAK-2; p58 | Homo sapiens (human) |
| Rapamycin-insensitive companion of mTOR | AVO3 homolog; hAVO3 | Homo sapiens (human) |
| Target of rapamycin complex subunit LST8 | TORC subunit LST8; G protein beta subunit-like; Gable; Protein GbetaL; Mammalian lethal with SEC13 protein 8; mLST8 | Homo sapiens (human) |
| Proto-oncogene vav | | Homo sapiens (human) |
| Membrane protein | M; E1 glycoprotein; Matrix glycoprotein; Membrane glycoprotein | Severe acute respiratory syndrome coronavirus 2 |
| T-lymphocyte activation antigen CD86 | Activation B7-2 antigen; B70; BU63; CTLA-4 counter-receptor B7.2; FUN-1 | Homo sapiens (human) |
| GRB2-related adapter protein 2 | Adapter protein GRID; GRB-2-like protein; GRB2L; GRBLG; GRBX; Grf40 adapter protein; Grf-40; Growth factor receptor-binding protein; Hematopoietic cell-associated adapter protein GrpL; P38; Protein GADS; SH3-SH2-SH3 adapter Mona | Homo sapiens (human) |
| T-lymphocyte activation antigen CD80 | Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7 | Homo sapiens (human) |
| Proline-rich protein 5 | Protein observed with Rictor-1; Protor-1 | Homo sapiens (human) |